NCT01312922 - Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD) | Biotech Hunter

Enrollment

555

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions

Major Depressive Disorder

Interventions

DRUG

PNB01 fixed dose combination of pipamperone and citalopram

oral once daily administration

DRUG

Citalopram

oral once daily administration

DRUG

Pipamperone

oral once daily administration

Trial Locations (31)

Unknown

Site 103, Glendale

Site 101, National City

Site 113, Riverside

Site 106, San Diego

Site 116, San Diego

Site 112, Fort Myers

Site 135, Miami

Site 108, Winter Park

Site 133, Atlanta

Site 128, Smyrna

Site 132, Libertyville

Site 117, Schaumburg

Site 110, Baltimore

Site 109, Flowood

Site 115, New York

Site 126, Beachwood

Site 127, Cincinnati

Site 124, Middleburg Heights

Site 105, Allentown

Site 123, Media

Site 122, Philadelphia

Site 119, Austin

Site 104, Dallas

Site 102, Wichita Falls

Site 107, Kirkland

Site 134, Seattle

Site 201, Kelowna

Site 202, Penticton

Site 205, Chatham

Site 203, Mississauga

Site 204, Mississauga

All Listed Sponsors

lead

PharmaNeuroBoost N.V.

INDUSTRY